These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39029646)

  • 21. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
    Sasagawa Y; Akai T; Tachibana O; Iizuka H
    J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
    Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
    J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
    Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
    BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
    Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
    Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
    Lossos IS; Breuer R; Intrator O; Lossos A
    Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
    Hottenrott T; Schorb E; Fritsch K; Dersch R; Berger B; Huzly D; Rauer S; Tebartz van Elst L; Endres D; Stich O
    J Neurol; 2018 May; 265(5):1106-1114. PubMed ID: 29511863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.
    Mabray MC; Barajas RF; Villanueva-Meyer JE; Zhang CA; Valles FE; Rubenstein JL; Cha S
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):74-9. PubMed ID: 26381553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma.
    Baraniskin A; Kuhnhenn J; Schlegel U; Schmiegel W; Hahn S; Schroers R
    J Neurooncol; 2012 Sep; 109(2):239-44. PubMed ID: 22729947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors.
    Ma J; Lin Z; Zhang Y; Ding Y; Tang Q; Qian Y; Jin B; Luo RY; Liao WL; Thyparambil S; Han Z; Chou CJ; Schilling J; Li Q; Zhang M; Lin Y; Ma Y; Sylvester KG; Nagpal S; McElhinney DB; Ling XB; Chen B
    Front Immunol; 2024; 15():1343109. PubMed ID: 39144147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma.
    Shao J; Chen K; Li Q; Ma J; Ma Y; Lin Z; Kang H; Chen B
    Cancer Manag Res; 2020; 12():6261-6268. PubMed ID: 32801871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.
    Deng Y; Li Q; Sun J; Ma L; Ding Y; Cai Y; Iliuk A; Chen B; Xie Z; Tao WA
    Analyst; 2023 Jul; 148(15):3594-3602. PubMed ID: 37403840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
    Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
    Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Corticosteroids Reduce Diagnostic Accuracy of Stereotactic Biopsies in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.
    Tosefsky K; Rebchuk AD; Martin KC; Chen DW; Yip S; Makarenko S
    Neurosurgery; 2024 Oct; 95(4):740-750. PubMed ID: 38865324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.
    Mao X; Sun Y; Tang J
    Neurol Sci; 2014 Feb; 35(2):233-8. PubMed ID: 23832112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas.
    Fischer L; Jahnke K; Martus P; Weller M; Thiel E; Korfel A
    Haematologica; 2006 Mar; 91(3):429-30. PubMed ID: 16531273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
    Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
    Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of cerebrospinal fluid free light chain in diagnosis of primary central nervous system lymphoma and monitoring of associated chemotherapy efficacy.
    Hu Y; Xiang J; Luo X; Lu M; Xu D; Chen B; Guan M
    Clin Chim Acta; 2022 Aug; 533():48-52. PubMed ID: 35716705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
    Cheng CL; Yao CY; Huang PH; Yu CW; Fang WQ; Chuang WH; Wu SJ; Lin YJ; Hung YC; Tsai CH; Yu SC; Chou WC; Tien HF
    Br J Haematol; 2023 Apr; 201(1):75-85. PubMed ID: 36480431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.
    Gleissner B; Siehl J; Korfel A; Reinhardt R; Thiel E
    Neurology; 2002 Feb; 58(3):390-6. PubMed ID: 11839837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.